TODD STRATEGY GROUP

Lobbying for ASTELLAS PHARMA US, INC. · Pharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate · $50,000.00 income · posted Oct 11, 2025

Lobbying activity 2

Pharmacy

Prescription drug pricing.

Health Issues

Prostate cancer screening. Women's health.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem